71 related articles for article (PubMed ID: 2605832)
1. [The significance of measurement of contents of serum serine protease inhibitors in senile dementia of the Alzheimer type].
Amari M; Matsubara E; Ishiguro K; Shoji M; Hirai S
Rinsho Shinkeigaku; 1989 Oct; 29(10):1256-60. PubMed ID: 2605832
[TBL] [Abstract][Full Text] [Related]
2. Serum concentration of alpha 1-antichymotrypsin is elevated in patients with senile dementia of the Alzheimer type.
Matsubara E; Amari M; Shoji M; Harigaya Y; Yamaguchi H; Okamoto K; Hirai S
Prog Clin Biol Res; 1989; 317():707-14. PubMed ID: 2690117
[TBL] [Abstract][Full Text] [Related]
3. Alpha 1-antichymotrypsin as a possible biochemical marker for Alzheimer-type dementia.
Matsubara E; Hirai S; Amari M; Shoji M; Yamaguchi H; Okamoto K; Ishiguro K; Harigaya Y; Wakabayashi K
Ann Neurol; 1990 Oct; 28(4):561-7. PubMed ID: 2147546
[TBL] [Abstract][Full Text] [Related]
4. [Clinical findings in Alzheimer dementia and multi-infarct dementia].
Wendland KL
Z Gerontol; 1991; 24(1):27-32. PubMed ID: 2038886
[TBL] [Abstract][Full Text] [Related]
5. Measurement of phosphorylated tau epitopes in the differential diagnosis of Alzheimer disease: a comparative cerebrospinal fluid study.
Hampel H; Buerger K; Zinkowski R; Teipel SJ; Goernitz A; Andreasen N; Sjoegren M; DeBernardis J; Kerkman D; Ishiguro K; Ohno H; Vanmechelen E; Vanderstichele H; McCulloch C; Moller HJ; Davies P; Blennow K
Arch Gen Psychiatry; 2004 Jan; 61(1):95-102. PubMed ID: 14706948
[TBL] [Abstract][Full Text] [Related]
6. Cerebrospinal fluid cholinesterases in aging and in dementia of the Alzheimer type.
Atack JR; May C; Kaye JA; Kay AD; Rapoport SI
Ann Neurol; 1988 Feb; 23(2):161-7. PubMed ID: 3377438
[TBL] [Abstract][Full Text] [Related]
7. Plasma and cerebrospinal fluid alpha1-antichymotrypsin levels in Alzheimer's disease: correlation with cognitive impairment.
DeKosky ST; Ikonomovic MD; Wang X; Farlow M; Wisniewski S; Lopez OL; Becker JT; Saxton J; Klunk WE; Sweet R; Kaufer DI; Kamboh MI
Ann Neurol; 2003 Jan; 53(1):81-90. PubMed ID: 12509851
[TBL] [Abstract][Full Text] [Related]
8. Cognitive test profile analysis for the identification of dementia of the Alzheimer type.
Christensen KJ; Multhaup KS; Nordstrom S; Voss K
Alzheimer Dis Assoc Disord; 1990; 4(2):96-109. PubMed ID: 2357342
[TBL] [Abstract][Full Text] [Related]
9. [Analytic study on EEG features of aging with/without psychiatric disorders: focussing at the alterations in the EEGs of the healthy, depressive and demented elderlies].
Saito N
Seishin Shinkeigaku Zasshi; 1995; 97(10):801-24. PubMed ID: 8552725
[TBL] [Abstract][Full Text] [Related]
10. [EEG background activity in patients with dementia of the Alzheimer type--with special reference to analysis by t-statistic significance probability mapping (SPM) in Alzheimer's disease and senile dementia].
Miyauchi T; Hagimoto H; Saito T; Endo K; Ishii M; Yamaguchi T; Kajiwara A; Matsushita M
Seishin Shinkeigaku Zasshi; 1989; 91(4):244-59. PubMed ID: 2798586
[TBL] [Abstract][Full Text] [Related]
11. Immunocytochemical study of alpha 1-antichymotrypsin in the senescent cerebral amyloid.
Shoji M; Harigaya Y; Yamaguchi H; Okamoto K; Hirai S; Takatama M
Prog Clin Biol Res; 1989; 317():1049-59. PubMed ID: 2690085
[TBL] [Abstract][Full Text] [Related]
12. Abnormal profile of serum proteinase inhibitors in cancer patients.
Chawla RK; Rausch DJ; Miller FW; Vogler WR; Lawson DH
Cancer Res; 1984 Jun; 44(6):2718-23. PubMed ID: 6722803
[TBL] [Abstract][Full Text] [Related]
13. [Acetylcholinesterase activity in CSF in senile dementia of Alzheimer type, vascular dementia, and Parkinson's disease].
Yoshinaga J; Sasaki T; Ideshita H; Hikiji A; Kuwaki T
Rinsho Shinkeigaku; 1989 Mar; 29(3):376-8. PubMed ID: 2752667
[TBL] [Abstract][Full Text] [Related]
14. Association of an apolipoprotein CII allele with familial dementia of the Alzheimer type.
Schellenberg GD; Deeb SS; Boehnke M; Bryant EM; Martin GM; Lampe TH; Bird TD
J Neurogenet; 1987 Apr; 4(2-3):97-108. PubMed ID: 2885403
[TBL] [Abstract][Full Text] [Related]
15. Plasma levels of alpha1-antichymotrypsin and secretory leukocyte proteinase inhibitor in healthy and chronic obstructive pulmonary disease (COPD) subjects with and without severe alpha1-antitrypsin deficiency.
Hollander C; Westin U; Wallmark A; Piitulainen E; Sveger T; Janciauskiene SM
BMC Pulm Med; 2007 Jan; 7():1. PubMed ID: 17261175
[TBL] [Abstract][Full Text] [Related]
16. Neural cell adhesion molecule in human serum. Increased levels in dementia of the Alzheimer type.
Todaro L; Puricelli L; Gioseffi H; Guadalupe Pallotta M; Lastiri J; Bal de Kier Joffé E; Varela M; Sacerdote de Lustig E
Neurobiol Dis; 2004 Mar; 15(2):387-93. PubMed ID: 15006709
[TBL] [Abstract][Full Text] [Related]
17. Serum concentration of alpha-2-macroglobulin, alpha-1-antitrypsin and alpha-1-antichymotrypsin [correction of alpha-2-antichymotrypsin] in patients with Hodgkin's disease.
Dabrowska M; Kemona H; Prokopowicz J; Kiluk S
Mater Med Pol; 1992; 24(1):28-30. PubMed ID: 1284980
[TBL] [Abstract][Full Text] [Related]
18. Accelerated weight loss may precede diagnosis in Alzheimer disease.
Johnson DK; Wilkins CH; Morris JC
Arch Neurol; 2006 Sep; 63(9):1312-7. PubMed ID: 16966511
[TBL] [Abstract][Full Text] [Related]
19. Reduced concentrations of several vitamins in normal weight patients with late-onset dementia of the Alzheimer type without vascular disease.
Glasø M; Nordbø G; Diep L; Bøhmer T
J Nutr Health Aging; 2004; 8(5):407-13. PubMed ID: 15359361
[TBL] [Abstract][Full Text] [Related]
20. Using verbal fluency to detect very mild dementia of the Alzheimer type.
Gomez RG; White DA
Arch Clin Neuropsychol; 2006 Dec; 21(8):771-5. PubMed ID: 17011743
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
